Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5 Versus 10 Units of Insulin in Hyperkalemia Management
NCT06036823Phase 4Completed
- Sponsor
- Oman Medical Specialty Board
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in hyperkalemia, sponsored by Oman Medical Specialty Board. Started Oct 2023; status: completed.
02
Drugs
human insulin
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT06036823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06036823.